Tetrahydroaminoacridine in Alzheimer's dementia: Clinical and biochemical results of a double‐blind crossover trial
- 1 June 1991
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 6 (2) , 109-118
- https://doi.org/10.1002/hup.470060205
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- CHOLINERGIC SIDE-EFFECTS OF TETRAHYDROAMINOACRIDINEThe Lancet, 1988
- Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptorsNeuroscience Letters, 1988
- Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's diseaseLife Sciences, 1988
- Cholinergic Drugs in Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- Inhibition of Cholinesterases by Tetrahydroaminacrin.Acta Chemica Scandinavica, 1961